Candida auris inpatient screening in collaboration with the public health department

Am J Infect Control. 2024 Aug;52(8):981-983. doi: 10.1016/j.ajic.2024.05.010. Epub 2024 May 16.

Abstract

Candida auris is a multidrug-resistant fungal pathogen that is associated with nosocomial outbreaks in patients with extensive health care exposure and treatment outside the United States. The Ohio Department of Health recommends C auris screening in high-risk patients. However, this can be operationally difficult for many health care facilities. This report describes a C auris and carbapenem-resistant Enterobacterales inpatient screening program done in collaboration with state public health.

Keywords: Public health; Surveillance.

MeSH terms

  • Candida auris* / drug effects
  • Candidiasis* / diagnosis
  • Candidiasis* / drug therapy
  • Candidiasis* / microbiology
  • Carbapenem-Resistant Enterobacteriaceae / isolation & purification
  • Cross Infection* / microbiology
  • Enterobacteriaceae Infections / diagnosis
  • Enterobacteriaceae Infections / drug therapy
  • Enterobacteriaceae Infections / microbiology
  • Humans
  • Inpatients*
  • Mass Screening / methods
  • Ohio